Log in
Enquire now
‌

US Patent 7794426 Infusion pump system with contamination-resistant features

Patent 7794426 was granted and assigned to Asante Solutions on September, 2010 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
Asante Solutions
Asante Solutions
Date Filed
May 21, 2007
Date of Patent
September 14, 2010
Patent Application Number
11751278
Patent Citations Received
‌
US Patent 12106837 Occlusion resolution in medication delivery devices, systems, and methods
0
‌
US Patent 12005237 Medicament delivery device comprising a visual indicator
0
‌
US Patent 12064591 Infusion pump system and method
0
‌
US Patent 11712536 Flow mixers for respiratory therapy systems
0
‌
US Patent 11759573 Bent fluid path add on to a prefilled reservoir
‌
US Patent 11801360 Connections for humidification system
‌
US Patent 11801201 Medication and identification information transfer apparatus
‌
US Patent 11857767 Injector usable with different dimension cartridges
0
‌
US Patent 11865299 Infusion pump systems and methods
0
‌
US Patent 11878093 Usability features for respiratory humidification system
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7794426
Patent Primary Examiner
Nicholas D Lucchesi
Nicholas D Lucchesi

Find more entities like US Patent 7794426 Infusion pump system with contamination-resistant features

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.